Israel Englander Standard Biotools Inc. Transaction History

Millennium Management LLC

$207 Billion
Q2 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Standard Biotools Inc. stock. As of the latest transaction made, Millennium Management LLC holds 6,221,993 shares of LAB stock, worth $13.5 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,221,993

Previous 14,373,199 56.71%

Holding current value

$13.5 Million

Previous $39 Million 71.73%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.65 - $2.92 $13.4 Million - $23.8 Million	-8,151,206 Reduced 56.71%	6,221,993 $11 Million
Q1 2024 May 15, 2024	BUY	$1.87 - $2.78 $24.1 Million - $35.8 Million	12,895,282 Added 872.53%	14,373,199 $39 Million
Q4 2023 Feb 14, 2024	BUY	$1.59 - $2.73 $1.42 Million - $2.43 Million	891,650 Added 152.09%	1,477,917 $3.27 Million
Q2 2023 Aug 14, 2023	SELL	$1.47 - $2.56 $478,990 - $834,160	-325,844 Reduced 35.72%	586,267 $1.13 Million
Q1 2023 May 15, 2023	BUY	$1.3 - $2.24 $159,437 - $274,722	122,644 Added 15.54%	912,111 $1.78 Million
Q4 2022 Feb 14, 2023	SELL	$0.93 - $1.52 $121,450 - $198,499	-130,592 Reduced 14.19%	789,467 $924,000
Q3 2022 Nov 14, 2022	SELL	$1.1 - $2.06 $477,689 - $894,581	-434,263 Reduced 32.06%	920,059 $1.01 Million
Q2 2022 Aug 15, 2022	BUY	$1.6 - $3.99 $1.06 Million - $2.63 Million	659,831 Added 95.01%	1,354,322 $2.17 Million
Q1 2022 May 16, 2022	BUY	$2.8 - $3.96 $281,360 - $397,924	100,486 Added 16.92%	694,491 $2.49 Million
Q4 2021 Feb 14, 2022	SELL	$3.63 - $6.13 $8.2 Million - $13.8 Million	-2,258,509 Reduced 79.18%	594,005 $2.33 Million
Q3 2021 Nov 15, 2021	SELL	$5.5 - $7.41 $2.92 Million - $3.93 Million	-530,143 Reduced 15.67%	2,852,514 $18.8 Million
Q2 2021 Aug 16, 2021	BUY	$4.35 - $6.35 $9.92 Million - $14.5 Million	2,280,083 Added 206.8%	3,382,657 $20.8 Million
Q1 2021 May 17, 2021	SELL	$3.94 - $7.09 $2.21 Million - $3.97 Million	-560,513 Reduced 33.7%	1,102,574 $4.98 Million
Q4 2020 Feb 16, 2021	SELL	$5.45 - $8.65 $7.68 Million - $12.2 Million	-1,409,094 Reduced 45.87%	1,663,087 $9.98 Million
Q3 2020 Nov 16, 2020	BUY	$4.34 - $11.43 $5.26 Million - $13.9 Million	1,212,214 Added 65.17%	3,072,181 $22.8 Million
Q2 2020 Aug 14, 2020	BUY	$1.85 - $5.29 $1.79 Million - $5.12 Million	968,052 Added 108.54%	1,859,967 $7.46 Million
Q1 2020 May 14, 2020	BUY	$1.24 - $4.35 $936,188 - $3.28 Million	754,991 Added 551.39%	891,915 $2.27 Million
Q4 2019 Feb 14, 2020	BUY	$2.3 - $5.12 $179,393 - $399,344	77,997 Added 132.36%	136,924 $476,000
Q3 2019 Nov 14, 2019	SELL	$4.63 - $12.15 $4.25 Million - $11.2 Million	-918,528 Reduced 93.97%	58,927 $272,000
Q2 2019 Aug 15, 2019	SELL	$11.49 - $14.17 $2.95 Million - $3.64 Million	-256,947 Reduced 20.82%	977,455 $12 Million
Q1 2019 May 14, 2019	BUY	$8.47 - $14.36 $2.55 Million - $4.33 Million	301,406 Added 32.31%	1,234,402 $16.4 Million
Q4 2018 Feb 14, 2019	BUY	$7.18 - $8.83 $4.23 Million - $5.2 Million	588,862 Added 171.11%	932,996 $8.04 Million
Q3 2018 Nov 14, 2018	BUY	$5.92 - $8.35 $281,590 - $397,176	47,566 Added 16.04%	344,134 $2.58 Million
Q2 2018 Aug 14, 2018	SELL	$4.86 - $6.24 $460,149 - $590,809	-94,681 Reduced 24.2%	296,568 $1.77 Million
Q1 2018 May 15, 2018	BUY	$5.75 - $7.97 $2.15 Million - $2.98 Million	373,673 Added 2126.04%	391,249 $2.29 Million
Q4 2017 Feb 14, 2018	SELL	$4.46 - $6.45 $248,814 - $359,832	-55,788 Reduced 76.04%	17,576 $104,000
Q3 2017 Nov 14, 2017	BUY	$3.55 - $5.49 $260,442 - $402,768	73,364	73,364 $370,000

Others Institutions Holding LAB

# of Institutions

149

Shares Held

264M

Call Options Held

422K

Put Options Held

40.7K

View Full List

About STANDARD BIOTOOLS INC.

Ticker LAB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 78,654,800
Market Cap $171M
Description
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...

More about LAB

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account